흰 쥐 좌골신경 협착 손상 모델에서 4-Methylcatechol 투여가 이질통과 척수 신경영양인자에 미치는 영향 = The effect of 4-Methylcatechol treatment in chronic constrictive injury of the rat sciatic nerve on the allodynia and spinal neurotrophic factors

다국어 초록 (Multilingual Abstract)

Background: The effect of chronic administration of 4-methylcatechol known as a neurotrophic factor inducer on the allodynia and spinal neurotrophic factors was investigated in chronic constrictive injury of sciatic nerve in rats.
Methods: With the Sprague Dawly rat, sciatic nerve was loosely ligated with 4-0 chromic catgut and neuropathic pain model was made. The threshold for tactile allodynia was measured with von Frey hair by up-down method and cold allodynia was measured by dropping 20μl of 100% acetone on the dorsum of the injured foot. 4-Methylcatechol (100μg/kg, intraperitoneal) was injected once a day for 14 days and the effect on allodynia was compared with saline injected group. At 3, 7 and 14 days after injection, lumbar spinal cord was harvested and the mRNA content of nerve growth factor (NGF) and brain derived neurotrophic factor (BDNF) was measure by real time PCR.
Results: Mechanical and cold allodynia improved from 7 days after 4-methylcatechol administration. NGF and BDNF in spinal cord decreased compared to sham operated group. BDNF in lumbar spinal cord has increased tendency after treatment without statistical significance.
Conclusions: Chronic intraperitoneal administration of 4-methylcatechol may improve tactile and cold allodynia in chronic constrictive injury rat model of neuropathic pain. The BDNF mRNA in spinal cord might increase after 4-methylcatechol treatment.

다국어 초록 (Multilingual Abstract)

Background: The effect of chronic administration of 4-methylcatechol known as a neurotrophic factor inducer on the allodynia and spinal neurotrophic factors was investigated in chronic constrictive injury of sciatic nerve in rats.
Methods: With the Sprague Dawly rat, sciatic nerve was loosely ligated with 4-0 chromic catgut and neuropathic pain model was made. The threshold for tactile allodynia was measured with von Frey hair by up-down method and cold allodynia was measured by dropping 20μl of 100% acetone on the dorsum of the injured foot. 4-Methylcatechol (100μg/kg, intraperitoneal) was injected once a day for 14 days and the effect on allodynia was compared with saline injected group. At 3, 7 and 14 days after injection, lumbar spinal cord was harvested and the mRNA content of nerve growth factor (NGF) and brain derived neurotrophic factor (BDNF) was measure by real time PCR.
Results: Mechanical and cold allodynia improved from 7 days after 4-methylcatechol administration. NGF and BDNF in spinal cord decreased compared to sham operated group. BDNF in lumbar spinal cord has increased tendency after treatment without statistical significance.
Conclusions: Chronic intraperitoneal administration of 4-methylcatechol may improve tactile and cold allodynia in chronic constrictive injury rat model of neuropathic pain. The BDNF mRNA in spinal cord might increase after 4-methylcatechol treatment.

참고문헌 (Reference)

1 Cope DK, "Volatile anesthetics protect the ischemic rabbit myocardium from infarction" 86 : 699-709, 1997

2 Jordan JE, "The role of neutrophils in myocardial ischemia-reperfusion injury" 43 : 869-878, 1999

3 Javadov SA, "Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition" 45 : 360-369, 200

4 Yang CY, "Propofol inhibits cardiac L-Type calcium current in guinea pig ventricular myocytes" 84 : 626-635, 1996

5 Kokita N, "Propofol improves functional and metabolic recovery in ischemic reperfused isolated rat hearts" 86 : 252-258, 1998

6 Ko SH, "Propofol attenuates ischemia-reperfusion injury in the isolated rat heart" 85 : 719-724, 1997

7 Zhao ZQ, "Progressively developed myocardial apoptotic cell death during late phase of reperfusion" 6 : 279-290, 2001

8 Mangano DT, "Preoperative assessment and management. In: Cardiac Anesthesia. 4th" 3-39, 2005

9 Wiesbauer F, "Perioperative β-blockers for preventing surgery-related mortality and morbidity: a systematic review and meta-analysis" 104 : 27-41, 2007

10 Mangano DT, "Perioperative cardiac morbidity" 72 : 153-184, 1990

11 Badner NH, "Myocardial infarction after noncardiac surgery" 88 : 572-578, 1998

12 Ouattara A, "Myocardial and coronary effects of propofol in rabbits with compensated cardiac hypertrophy" 95 : 699-707, 2001

13 Zhou W, "Modulation of cardiac calcium channels by propofol" 86 : 670-675, 1997

14 Reves JG, "Intravenous nonopioid anesthetics. In: Miller's Anesthesia. 6th" 317-378, 2005

15 Riou B, "In vitro effects of propofol on rat myocardium" 76 : 609-616, 1992

16 Simpson PJ, "Identification of a time window for therapy to reduce experimental canine myocardial injury: suppression of neutrophil activation during 72 hours of reperfusion" 63 : 1070-1079, 0988

17 Tamaki F, "Effects of propofol on ischemia and reperfusion in the isolated rat heart compared with thiamylal" 42 : 193-206, 2001

18 Nakaigawa Y, "Effects of graded infusion rates of propofol on cardiovascular hemodynamics, coronary circulation and myocardial metabolism in dogs" 75 : 616-621, 1995

19 Ebel D, "Effect of propofol on reperfusion injury after regional ischaemia in the isolated rat heart" 83 : 903-908, 1999

20 Schlack W, "Effect of heart rate reduction by 4-(N-ethyl-N-phenyl-amino)-1,2- dimethyl-6-(methylamino)pyrimidinium chloride on infarct size in dog" 48 : 26-33, 1998

21 Zhao ZQ, "Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion" 94 : 133-144, 2000

22 Xia Z, "Dose-dependent protection of cardiac function by propofol during ischemia and early reperfusion in rats: effects on 15-F2t-isoprostane formation" 81 : 14-21, 2003

23 Mark DB, "Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty" 89 : 2015-2025, 1994

24 Schulz R, "Bradycardic agent UL-FS 49 attenuates ischemic regional myocardial dysfunction and reduces infarct size in swine: comparison with the beta-blocker atenolol" 25 : 216-228, 1995

25 Nayler WG, "Basic mechanisms involved in the protection of the ischaemic myocardium. the role of calcium antagonists" 42 : 21-27, 1991

26 Warltier DC, "Approaches to the prevention of perioperative myocardial ischemia" 92 : 253-259, 2000